A prototype for doing a skin biopsy in 5 minutes and a simulator for training doctors in minimally invasive surgery are some of the innovative projects in the process of being patented that have arisen from the relationship between the university and medical centers in the region. These are some of the examples that were spoken of at the 2nd Meeting between the UC3M and the Madrid center of the Platform for Innovation in Medical and Healthcare Technology.
A major investment in gene sequencing technology will secure Scotland's place as a world leader in a genomics revolution that is set to transform healthcare. The Universities of Edinburgh and Glasgow are to partner with Illumina the global leader in sequencing and genomics, in the £15 million project.
Data from a Phase 1b study demonstrate a marked anti-tumor activity in patients with relapsed SCLC treated with PM01183 in combination with doxorubicin, which was in general well-tolerated and induced several complete responses. PharmaMar will start a pivotal Phase 3 trial to compare PM01183 plus doxorubicin against topotecan in relapsed SCLC as second-line therapy, the only drug approved by the EMA and the FDA for this indication
The University of Texas MD Anderson Cancer Center and Amgen have announced a research collaborative agreement focusing on Amgen's bispecific T cell engager (BiTE®) antibody constructs, an immunotherapy that serves as a 'bridge' between T cells and cancer cells.
Novella Clinical, a Quintiles company (Novella), and the Cardiovascular Research Foundation (CRF) today announced a preferred provider collaboration that will offer a set of clinical trial services to developers of cardiovascular drugs and devices.
All six instruments that will fly on the National Oceanic and Atmospheric Administration Geostationary Operational Satellite R have now completed integration onto the spacecraft.
An innovative new program developed at the University of Washington was designed specifically to help parents of children in foster care navigate the process of court-ordered visitations and become better parents. Called STRIVE, will be offered at no cost online and aims to reunite families while reducing the tremendous costs associated with children in care.
The College of American Pathologists, the International Association for the Study of Lung Cancer, and the Association for Molecular Pathology are teaming to revise the evidence-based guideline, 'Molecular Testing Guideline for Selection of Lung Cancer Patients for EGFR and ALK Tyrosine Kinase Inhibitors.'
ORNL's newest 3-D printed vehicle pays homage to the classic Shelby Cobra in celebration of the racing car's 50th anniversary.
23andMe, Inc., the leading personal genetics company, today announced an agreement with Pfizer Inc. that will provide Pfizer with access to 23andMe's research platform, including services and Research Portal analysis of 23andMe's genotyped population of over 800,000 individuals, of which more than 80 percent have consented to participate in research.